The overall objective of GALILEO is to rely on genuine Multi-Actor Approaches (MAA) to co-develop context-specific, people-centered agroforestry innovations in representative agro-pastoral, agroforestry, and agro-silvo-pastoral systems from Sub-Saharan Africa (SSA). The aim is to promote agroforestry as leverage to significantly improve agricultural, household, and climate change adaptation and mitigation performances and to enhance biodiversity in SSA. We build upon 8 agroforestry Living Labs (LLs: local scale and actors), 4 national and 1 regional Innovation Platforms (IPs), set up across 4 AU SSA countries. Our LLs are set in semi-arid zones of Senegal and Kenya and normally humid but drought-prone zones of Ghana and Cameroon thus comparing and covering a large range of SSA conditions. Through MMA, we co-construct potentially adoptable scenarios ex-ante with Innovator, Target, and Control actors in our LLs, then implement, assess, and compare performances in their pilot plots during the whole project. We use field observations also to calibrate process models, able to simulate under future CC scenarios. After full multi-criteria and trade-off analysis, we finally co-select the most effective scenarios ex-post. We thus rely on transdisciplinary research, providing qualitative and quantitative data on the biophysical, socio-economic, and environmental performances. Such adoptable agroforestry innovations will also enable farmers/pastoralists and stakeholders to diversify their incomes from new agroforestry value chains, of which 2 are GALILEO-original. They will also benefit from carbon farming and payment for ecosystem services opportunities. Through our IPs, we also engage in solid MAA collaborations and policy dialogues to first identify bottlenecks and second elaborate guidelines, and policy recommendations, helping towards strengthening their local innovation ecosystems, under a favorable institutional and policy framework.

The objective of FarFish is to improve knowledge on and management of EU fisheries outside Europe, while contributing to sustainability and long term profitability. 21% of EU catches originate from non-EU waters. These fisheries are often poorly regulated, management decisions are sometimes based on limited knowledge and enforcement capabilities, compliance and trust between stakeholders tend to lack. FarFish will address these shortcomings in a multidisciplinary and innovative way by focusing on six diverse case studies, four in Sustainable Fisheries Partnership Agreement (SFPA) waters and two in international waters. Firstly, FarFish will analyse biological, ecological, technological, economic, political and social impacts of EU fisheries in the case studies to advance knowledge and promote sustainable and profitable exploitation. Secondly, introduce Results-Based Management approaches and new decision support tools into these fisheries and test their applicability in collaboration with stakeholders. Thirdly, build capacities in fisheries management and related disciplines amongst stakeholders. The results of FarFish will both have immediate and long-term application. FarFish includes a diverse groups of stakeholders, EU and third country fleets representatives, scientists, decision makers, Regional Fisheries Management Organisations (RFMOs), relevant industries and stakeholders from areas outside the case studies but of importance for the EU fleet, forming a platform for future cooperation between EU and third countries. FarFish addresses the work programme by improving knowledge within the relevant fisheries, developing management tools and models, improving professional skills and sharing new findings in correspondence to the priorities of SFPAs, RFMOs and the CFP. FarFish will contribute to sustainable management, resilience and efficiency in the seafood value chains, increase European food security, boost long-term profitability and promote jobs.

Current vaccines for African horse sickness (AHS), peste des petits ruminants (PPR) and foot-and-mouth disease (FMD) have critical shortcomings that leave the European Union vulnerable to these category A transboundary animal diseases, but control strategies that rely on culling alone are increasingly rejected by the public. At the same time, the risk of an introduction of AHS, PPR or FMD into Europe is growing, driven by climate change, global trade and long-distance travel. Innovative vaccines and companion diagnostics that are grounded in an increased knowledge of pathogenesis and immunity are urgently required to improve the capacity to prevent introductions and contain outbreaks, which are a major threat to European agriculture. The SPIDVAC (Safe Priority Infectious Diseases VACcines) consortium consists of 13 partners from Germany, France, Spain, the United Kingdom, the Netherlands, South Africa and Senegal, who will develop innovative vaccines against AHS, PPR and FMD and evaluate their capabilities in vitro, demonstrate the safety and efficacy of the candidate vaccines in small-animal models and in the target species and develop companion diagnostic to reliably differentiate between infected and vaccinated animals (DIVA). In addition, the project will increase knowledge on the mechanisms of infection, virulence and immunity and study the acceptability of vaccines for stakeholders in endemic areas. The consortium includes industry partners for veterinary vaccines and diagnostic tools, who will ensure the technological readiness and market relevance of the newly developed tools, which will help policy makers, veterinary services and business operators reduce the burden of infectious animal diseases, contribute to a sustainable livestock industry and promote public and animal health from farm to fork.